Physiomics Plc (LON:PYC – Get Free Report) shares were up 20% on Wednesday . The stock traded as high as GBX 0.97 ($0.01) and last traded at GBX 0.93 ($0.01). Approximately 6,918,706 shares were traded during trading, an increase of 65% from the average daily volume of 4,186,623 shares. The stock had previously closed at GBX 0.78 ($0.01).
Physiomics Stock Up 10.7 %
The firm has a market cap of £1.74 million, a PE ratio of -13.83 and a beta of 1.69. The business has a 50-day moving average price of GBX 0.71 and a two-hundred day moving average price of GBX 0.73.
Insiders Place Their Bets
In related news, insider Peter Sargent bought 459,090 shares of the stock in a transaction on Thursday, November 7th. The shares were bought at an average cost of GBX 1 ($0.01) per share, for a total transaction of £4,590.90 ($5,727.17). 4.18% of the stock is owned by corporate insiders.
Physiomics Company Profile
Physiomics Plc provides consulting services to pharmaceutical companies in the areas of outsourced quantitative pharmacology and computational biology in the United Kingdom, the United States, and the European Union Switzerland. The company offers modeling, simulation, and data analysis services covering various ranges of oncology research and development using its proprietary Virtual Tumour predictive software.
Featured Stories
- Five stocks we like better than Physiomics
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- 100% Upside? Amprius Technologies Is Charged for Growth in 2025
- Best Aerospace Stocks Investing
- The 5 Stocks Congress Bought Most in 2024: Top Picks for 2025
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- 3 Stocks Set to Benefit From Trump’s “Drill, Baby, Drill” Policy
Receive News & Ratings for Physiomics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Physiomics and related companies with MarketBeat.com's FREE daily email newsletter.
